Stay updated with breaking news from High Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oppenheimer Asset Management Inc. lowered its position in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 1.7% in the 2nd quarter, HoldingsChannel reports. The fund owned 69,083 shares of the health services provider’s stock after selling 1,195 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Amedisys were worth $6,317,000 as of its most recent […]
Amedisys (NASDAQ:AMED – Get Free Report) released its quarterly earnings data on Tuesday. The health services provider reported $0.98 earnings per share for the quarter, missing the consensus estimate of $1.08 by ($0.10), Briefing.com reports. Amedisys had a net margin of 0.10% and a return on equity of 14.00%. The firm had revenue of $556.24 […]
StockNews.com initiated coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research note published on Sunday morning. The firm issued a buy rating on the health services provider’s stock. Other research analysts have also issued research reports about the stock. Jefferies Financial Group lowered shares of Amedisys from a buy rating to a […]
StockNews.com started coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a report published on Saturday morning. The brokerage issued a buy rating on the health services provider’s stock. A number of other equities analysts have also recently issued reports on the stock. Jefferies Financial Group cut shares of Amedisys from a buy rating […]
StockNews.com started coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research report sent to investors on Saturday morning. The brokerage issued a buy rating on the health services provider’s stock. A number of other research firms have also recently commented on AMED. Jefferies Financial Group cut Amedisys from a buy rating to […]